Karyopharm Therapeutics (KPTI) To Webcast Investor & Analyst Briefing On Monday, June 2, 2014
5/30/2014 9:13:58 AM
NATICK, Mass., May 30, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI), a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, invites investors and the general public to listen to a webcast of its Investor & Analyst Briefing on Monday, June 2 at 6:15 PM Central Time. At this briefing, Karyopharm's management team will provide a clinical update in conjunction with the 2014 American Society of Clinical Oncology (ASCO) annual meeting.
Help employers find you! Check out all the jobs and post your resume.
comments powered by